1. Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib. Issue 5 (October 2020) Authors: Vidarsdottir, Linda; Fernandes, Rita Valador; Zachariadis, Vasilios; Das, Ishani; Edsbäcker, Elin; Sigvaldadottir, Ingibjorg; Azimi, Alireza; Höiom, Veronica; Hansson, Johan; Grandér, Dan; Egyházi Brage, Suzanne; Pokrovskaja Tamm, Katja Journal: Melanoma research Issue: Volume 30:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗